AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 15563708 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualised unsupervised home based exercise programme (3 sessions per week)
Number of subjects: 48
Study 15563708 — intervention group
Group type: COMPARATOR
Intervention: Control group (no exercise programme)
Number of subjects: 48
Study 11482465 — intervention group
Group type: EXPERIMENTAL
Intervention: Decompression of the posterior interosseous nerve (PIN)
Number of subjects: 28
Study 11482465 — intervention group
Group type: EXPERIMENTAL
Intervention: Lengthening of the distal tendon of the extensor carpi radialis brevis (ECRB)
Number of subjects: 28
Study 11482465 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall outcome after a mean follow-up of 31 months
Number of subjects: 28
Study 9783935 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.4 mg tamsulosin
Number of subjects: 735
Study 9783935 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.8 mg tamsulosin
Number of subjects: 735
Study 7870010 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum TPA values
Number of subjects: 100
Study 2974263 — intervention group
Group type: EXPERIMENTAL
Intervention: procaterol 0.05 mg twice daily for 2 wk followed by 0.10 mg twice daily for 10 wk
Number of subjects: 223
Study 2974263 — intervention group
Group type: COMPARATOR
Intervention: albuterol 2 mg three times a day for 2 wk followed by 4 mg three times a day for 10 wk
Number of subjects: 223
Study 2974263 — intervention group
Group type: EXPERIMENTAL
Intervention: procaterol
Number of subjects: 223
Study 2974263 — intervention group
Group type: COMPARATOR
Intervention: albuterol
Number of subjects: 223
Study 2974263 — intervention group
Group type: EXPERIMENTAL
Intervention: procaterol and albuterol
Number of subjects: 223
Study 30530121 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral β‐blocker therapy
Number of subjects: 10000
Study 30530121 — intervention group
Group type: COMPARATOR
Intervention: No β‐blocker therapy
Number of subjects: 10000
Study 29534639 — intervention group
Group type: EXPERIMENTAL
Intervention: Sunitinib as an adjunct to standard therapy (leucovorin, 5-fluorouracil, and irinotecan)
Number of subjects: 52
Study 29534639 — intervention group
Group type: COMPARATOR
Intervention: Placebo as an adjunct to standard therapy (leucovorin, 5-fluorouracil, and irinotecan)
Number of subjects: 52
Study 29534639 — intervention group
Group type: EXPERIMENTAL
Intervention: Sunitinib
Number of subjects: 52
Study 29534639 — intervention group
Group type: COMPARATOR
Intervention: Standard therapy (leucovorin, 5-fluorouracil, and irinotecan)
Number of subjects: 52
Study 26467679 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoride varnish (FV)
Number of subjects: 518
Study 26467679 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral health promotion (OHP) activities
Number of subjects: 518
Study 26467679 — intervention group
Group type: EXPERIMENTAL
Intervention: Parent participation
Number of subjects: 518
Study 24457412 — intervention group
Group type: EXPERIMENTAL
Intervention: Rhinovirus infection
Number of subjects: 25
Study 22057424 — intervention group
Group type: EXPERIMENTAL
Intervention: β-glucan-enriched beverage (3 g barley β-glucan)
Number of subjects: 14
Study 22057424 — intervention group
Group type: EXPERIMENTAL
Intervention: Fruit-based beverage (2.5 g dietary fibre)
Number of subjects: 14
Study 22057424 — intervention group
Group type: COMPARATOR
Intervention: Control (without dietary fibre)
Number of subjects: 14
Study 21200103 — intervention group
Group type: EXPERIMENTAL
Intervention: Levosimendan
Number of subjects: 50
Study 21200103 — intervention group
Group type: COMPARATOR
Intervention: Dobutamine
Number of subjects: 50
Study 21200103 — intervention group
Group type: EXPERIMENTAL
Intervention: Levosimendan and Dobutamine
Number of subjects: 50
Study 17374316 — intervention group
Group type: EXPERIMENTAL
Intervention: Efalizumab 1 mg/kg weekly for 12 weeks
Number of subjects: 115
Study 17374316 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 115
Study 15838685 — intervention group
Group type: EXPERIMENTAL
Intervention: Casein hydrolysate (Nutramigen; Mead Johnson)
Number of subjects: 242
Study 15838685 — intervention group
Group type: COMPARATOR
Intervention: Conventional cow's milk-based formula
Number of subjects: 242
Study 12181364 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate intensity exercise
Number of subjects: 140
Study 12181364 — intervention group
Group type: COMPARATOR
Intervention: Reference group (control)
Number of subjects: 140
Study 10460557 — intervention group
Group type: EXPERIMENTAL
Intervention: Etomidate
Number of subjects: 35
Study 10460557 — intervention group
Group type: COMPARATOR
Intervention: Thiopentone
Number of subjects: 35
Study 7598055 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet with energy density of 1.67, 2.93, 4.18, or 6.28 kJ/g fed ad libitum three, four, or five times per day
Number of subjects: 18
Study 2220978 — intervention group
Group type: EXPERIMENTAL
Intervention: 200,000 IU of oral vitamin A
Number of subjects: 88
Study 2220978 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 88
Study 619324 — intervention group
Group type: EXPERIMENTAL
Intervention: 5-fluorouracil plus melphalan (5-FU + Melphalan)
Number of subjects: 57
Study 619324 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination chemotherapeutic agents (ACFUME, ACFUCY)
Number of subjects: 57
Study 619324 — intervention group
Group type: EXPERIMENTAL
Intervention: ACFUME and ACFUCY combinations
Number of subjects: 57
Study 619324 — intervention group
Group type: EXPERIMENTAL
Intervention: Complete response patients
Number of subjects: 57
Study 31028057 — intervention group
Group type: EXPERIMENTAL
Intervention: Indinavir (10 μM)
Number of subjects: 8
Study 30220280 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin caliper for blood glucose control
Number of subjects: 92
Study 30220280 — intervention group
Group type: COMPARATOR
Intervention: Conventional group (paper-based insulin dose modification scheme)
Number of subjects: 92
Study 27217097 — intervention group
Group type: EXPERIMENTAL
Intervention: High-purity plasma-derived factor X concentrate (pdFX) administered preoperatively to raise FX:C to 70-90 IU dL(‐1) and postoperatively to maintain levels >50 IU dL(‐1) until no longer at risk of bleeding due to surgery.
Number of subjects: 5
Study 24161781 — intervention group
Group type: EXPERIMENTAL
Intervention: MR-guided RF ablation
Number of subjects: 35
Study 24161781 — intervention group
Group type: COMPARATOR
Intervention: CT-guided RF ablation
Number of subjects: 35
Study 24161781 — intervention group
Group type: EXPERIMENTAL
Intervention: Both MR and CT-guided RF ablation
Number of subjects: 35
Study 22112969 — intervention group
Group type: EXPERIMENTAL
Intervention: Docetaxel (75 mg/m2 day 1) and prednisone (5 mg orally twice daily every 21 days) plus AT-101 (40 mg twice daily on days 1-3)
Number of subjects: 221
Study 22112969 — intervention group
Group type: COMPARATOR
Intervention: Docetaxel (75 mg/m2 day 1) and prednisone (5 mg orally twice daily every 21 days) plus placebo
Number of subjects: 221
Study 22112969 — intervention group
Group type: EXPERIMENTAL
Intervention: Docetaxel plus prednisone with AT-101
Number of subjects: 221
Study 22112969 — intervention group
Group type: COMPARATOR
Intervention: Docetaxel plus prednisone with placebo
Number of subjects: 221
Study 22112969 — intervention group
Group type: EXPERIMENTAL
Intervention: Docetaxel plus prednisone with AT-101 in high-risk mCRPC (n=34)
Number of subjects: 221
Study 22112969 — intervention group
Group type: COMPARATOR
Intervention: Docetaxel plus prednisone with placebo in high-risk mCRPC (n=34)
Number of subjects: 221
Study 20940688 — intervention group
Group type: EXPERIMENTAL
Intervention: Information on anxiolytic technique, local anesthesia, and treatment of perioperative pain
Number of subjects: 150
Study 20940688 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative visit information
Number of subjects: 150
Study 20940688 — intervention group
Group type: EXPERIMENTAL
Intervention: Loco-regional anesthesia
Number of subjects: 150
Study 17438342 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral treatment
Number of subjects: 25
Study 17438342 — intervention group
Group type: COMPARATOR
Intervention: Eclectic treatment
Number of subjects: 25
Study 15798963 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate to intense exercise training for 16 weeks
Number of subjects: 51
Study 15798963 — intervention group
Group type: COMPARATOR
Intervention: No exercise training (control)
Number of subjects: 51
Study 16678648 — intervention group
Group type: EXPERIMENTAL
Intervention: MAS XR 10 mg/d
Number of subjects: 287
Study 16678648 — intervention group
Group type: EXPERIMENTAL
Intervention: MAS XR 20 mg/d
Number of subjects: 287
Study 16678648 — intervention group
Group type: EXPERIMENTAL
Intervention: MAS XR 30 mg/d
Number of subjects: 287
Study 16678648 — intervention group
Group type: EXPERIMENTAL
Intervention: MAS XR 40 mg/d
Number of subjects: 287
Study 16678648 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 287
Study 10816404 — intervention group
Group type: EXPERIMENTAL
Intervention: Digital imaging (Group B)
Number of subjects: 144
Study 10816404 — intervention group
Group type: COMPARATOR
Intervention: Conventional X-ray (Group A)
Number of subjects: 144
Study 8870544 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-term psychotherapy
Number of subjects: 0
Study 8870544 — intervention group
Group type: EXPERIMENTAL
Intervention: Qualifications of providers
Number of subjects: 0
Study 8870544 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical judgment versus case management
Number of subjects: 0
Study 1517643 — intervention group
Group type: EXPERIMENTAL
Intervention: Phenytoin (PHT) 100 mg by mouth twice daily
Number of subjects: 75
Study 1517643 — intervention group
Group type: EXPERIMENTAL
Intervention: Buprenorphine (Bu) 0.2 mg sublingually twice daily
Number of subjects: 75
Study 1517643 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined therapy (PHT 50 mg PO + Bu 0.1 mg SL twice daily)
Number of subjects: 75
Study 6149671 — intervention group
Group type: EXPERIMENTAL
Intervention: Prenalterol (100‐200 mg daily)
Number of subjects: 10
Study 6149671 — intervention group
Group type: COMPARATOR
Intervention: Intensified treatment with diuretics
Number of subjects: 10
Study 6149671 — intervention group
Group type: EXPERIMENTAL
Intervention: Prenalterol
Number of subjects: 10
Study 6149671 — intervention group
Group type: COMPARATOR
Intervention: Control periods / intensified conventional treatment
Number of subjects: 10
Study 30412325 — intervention group
Group type: EXPERIMENTAL
Intervention: Elbasvir/grazoprevir (EBR/GZR) for 12 weeks
Number of subjects: 957
Study 30412325 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline viral load cutpoint of 800,000 IU/mL
Number of subjects: 957
Study 30412325 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline NS5A resistance‐associated substitutions (RASs)
Number of subjects: 957
Study 28436380 — intervention group
Group type: EXPERIMENTAL
Intervention: Tenofovir disoproxil fumarate (TDF) monotherapy
Number of subjects: 60
Study 28436380 — intervention group
Group type: COMPARATOR
Intervention: Entecavir-adefovir dipivoxil (ETV-ADV) combination therapy
Number of subjects: 60
Study 28091491 — intervention group
Group type: EXPERIMENTAL
Intervention: SMC‐phoresis of the bromine‐chlorine brine
Number of subjects: 80
Study 28091491 — intervention group
Group type: COMPARATOR
Intervention: Standard pharmaceutical treatment for IBS (myotropic anti‐spasmodics and lactulose)
Number of subjects: 80
Study 25534310 — intervention group
Group type: EXPERIMENTAL
Intervention: Out & Online program (online mental health and wellbeing program)
Number of subjects: 200
Study 25534310 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control group
Number of subjects: 200
Study 22281004 — intervention group
Group type: EXPERIMENTAL
Intervention: Donepezil (5 mg for the first two weeks, 10 mg for the last two weeks)
Number of subjects: 21
Study 20133263 — intervention group
Group type: EXPERIMENTAL
Intervention: Albumin-bound paclitaxel weekly for 12 weeks followed by 5-fluorouracil/epirubicin/cyclophosphamide (FEC) every 3 weeks for 4 cycles
Number of subjects: 66
Study 20133263 — intervention group
Group type: EXPERIMENTAL
Intervention: Albumin-bound paclitaxel
Number of subjects: 66
Study 20133263 — intervention group
Group type: EXPERIMENTAL
Intervention: FEC
Number of subjects: 66
Study 18751500 — intervention group
Group type: EXPERIMENTAL
Intervention: Test formulation containing 400 mg dexibuprofen
Number of subjects: 24
Study 18751500 — intervention group
Group type: COMPARATOR
Intervention: Reference formulation containing 400 mg dexibuprofen
Number of subjects: 24
Study 15933924 — intervention group
Group type: COMPARATOR
Intervention: HUT (Helicobacter urease testing)
Number of subjects: 119
Study 15933924 — intervention group
Group type: EXPERIMENTAL
Intervention: GBT (gastroscopic breath testing)
Number of subjects: 119
Study 15933924 — intervention group
Group type: COMPARATOR
Intervention: HUT
Number of subjects: 119
Study 15933924 — intervention group
Group type: EXPERIMENTAL
Intervention: GBT
Number of subjects: 119
Study 12873919 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.125% levobupivacaine
Number of subjects: 60
Study 12873919 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.20% levobupivacaine
Number of subjects: 60
Study 12873919 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.25% levobupivacaine
Number of subjects: 60
Study 10372564 — intervention group
Group type: EXPERIMENTAL
Intervention: Gabapentin (600, 1200, or 2400 mg/day)
Number of subjects: 201
Study 8908676 — intervention group
Group type: EXPERIMENTAL
Intervention: LHRH agonist leuprolide depot for 24 weeks
Number of subjects: 41
Study 1677168 — intervention group
Group type: EXPERIMENTAL
Intervention: Clonidine
Number of subjects: 0
Study 1677168 — intervention group
Group type: EXPERIMENTAL
Intervention: Idazoxan
Number of subjects: 0
Study 1677168 — intervention group
Group type: COMPARATOR
Intervention: Maprotiline (active control)
Number of subjects: 0
Study 1677168 — intervention group
Group type: EXPERIMENTAL
Intervention: Clonidine, Idazoxan, Maprotiline
Number of subjects: 0
Study 31563241 — intervention group
Group type: EXPERIMENTAL
Intervention: Twice-Daily Tacrolimus (Prograf)
Number of subjects: 40
Study 31563241 — intervention group
Group type: COMPARATOR
Intervention: Once-Daily Tacrolimus (Advagraf)
Number of subjects: 40
Study 31563241 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (Twice-Daily and Once-Daily Tacrolimus)
Number of subjects: 40
Study 28420367 — intervention group
Group type: EXPERIMENTAL
Intervention: iFightDepression (iFD) tool + Treatment as Usual (TAU)
Number of subjects: 310
Study 28420367 — intervention group
Group type: COMPARATOR
Intervention: Internet-based psychoeducation + Treatment as Usual (TAU)
Number of subjects: 310
Study 28420367 — intervention group
Group type: EXPERIMENTAL
Intervention: iFightDepression (iFD) tool + TAU
Number of subjects: 310
Study 28420367 — intervention group
Group type: COMPARATOR
Intervention: Internet-based psychoeducation + TAU
Number of subjects: 310
Study 25377349 — intervention group
Group type: EXPERIMENTAL
Intervention: Cuidando a mis Cuidadores (Caring for My Caregivers) intervention, 8 sessions including skill-building workshops
Number of subjects: 0
Study 25377349 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 0
Study 23525950 — intervention group
Group type: EXPERIMENTAL
Intervention: rs2494262 of the FCER1A gene
Number of subjects: 562
Study 23525950 — intervention group
Group type: EXPERIMENTAL
Intervention: rs2427824 of the FCER1A gene
Number of subjects: 562
Study 23525950 — intervention group
Group type: EXPERIMENTAL
Intervention: SNPs in IL10, ADAM33, NOS1 and IL4R
Number of subjects: 562
Study 21306473 — intervention group
Group type: EXPERIMENTAL
Intervention: Caudal morphine-bupivacaine (100 μg·kg(‐1) morphine, mixed with 0.25% bupivacaine with 1 : 200,000 epinephrine)
Number of subjects: 64
Study 21306473 — intervention group
Group type: COMPARATOR
Intervention: Intravenous morphine (150 μg·kg(‐1)) with droperidol (75 μg·kg(‐1))
Number of subjects: 64
Study 21306473 — intervention group
Group type: EXPERIMENTAL
Intervention: Caudal morphine-bupivacaine
Number of subjects: 64
Study 21306473 — intervention group
Group type: COMPARATOR
Intervention: Intravenous morphine
Number of subjects: 64
Study 19687165 — intervention group
Group type: EXPERIMENTAL
Intervention: Atenolol-based regimen
Number of subjects: 9193
Study 19687165 — intervention group
Group type: EXPERIMENTAL
Intervention: Losartan-based regimen
Number of subjects: 9193
Study 19687165 — intervention group
Group type: EXPERIMENTAL
Intervention: QRS duration
Number of subjects: 9193
Study 19687165 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline QRS duration
Number of subjects: 9193
Study 19687165 — intervention group
Group type: EXPERIMENTAL
Intervention: Changes in ECG LVH severity
Number of subjects: 9193
Study 17881400 — intervention group
Group type: COMPARATOR
Intervention: IVIG 150 mg/kg on Day 1, placebo on Days 2 and 3 (Group I)
Number of subjects: 173
Study 17881400 — intervention group
Group type: EXPERIMENTAL
Intervention: IVIG 450 mg/kg on Day 1, 300 mg/kg on Day 2, 150 mg/kg on Day 3 (Group II)
Number of subjects: 173
Study 17881400 — intervention group
Group type: EXPERIMENTAL
Intervention: IVIG treatment (both groups)
Number of subjects: 173
Study 15473454 — intervention group
Group type: EXPERIMENTAL
Intervention: Ice
Number of subjects: 20
Study 15473454 — intervention group
Group type: COMPARATOR
Intervention: Water
Number of subjects: 20
Study 11558817 — intervention group
Group type: EXPERIMENTAL
Intervention: latanoprost 0.005% once daily plus timolol 0.5% twice daily
Number of subjects: 148
Study 11558817 — intervention group
Group type: COMPARATOR
Intervention: dorzolamide 2% twice daily plus timolol 0.5% twice daily
Number of subjects: 148
Study 9491039 — intervention group
Group type: EXPERIMENTAL
Intervention: Frozen solution (FS)
Number of subjects: 91
Study 9491039 — intervention group
Group type: COMPARATOR
Intervention: Conventional glucose electrolyte solution (CS)
Number of subjects: 91
Study 9491039 — intervention group
Group type: EXPERIMENTAL
Intervention: Frozen solution (FS) after crossover from CS
Number of subjects: 91
Study 9491039 — intervention group
Group type: COMPARATOR
Intervention: Conventional glucose electrolyte solution (CS) after crossover from FS
Number of subjects: 91
Study 7870490 — intervention group
Group type: EXPERIMENTAL
Intervention: Mellow music
Number of subjects: 60
Study 7870490 — intervention group
Group type: EXPERIMENTAL
Intervention: Frenetic music
Number of subjects: 60
Study 7870490 — intervention group
Group type: COMPARATOR
Intervention: White noise (control)
Number of subjects: 60
Study 3163133 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose cytotoxic therapy
Number of subjects: 20
Study 3163133 — intervention group
Group type: COMPARATOR
Intervention: Reference group with long-term hospitalization
Number of subjects: 20
Study 3163133 — intervention group
Group type: COMPARATOR
Intervention: Reference groups
Number of subjects: 20
Study 31748424 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural anesthesia plus 7% lidocaine cream applied around the chest tube insertion site 20 min before removal (Group L)
Number of subjects: 40
Study 31748424 — intervention group
Group type: COMPARATOR
Intervention: Epidural anesthesia plus placebo cream (Group P)
Number of subjects: 40
Study 28976835 — intervention group
Group type: EXPERIMENTAL
Intervention: Cryopreserved human umbilical cord (cUC) allograft with negative pressure wound therapy (NPWT)
Number of subjects: 13
Study 25800685 — intervention group
Group type: EXPERIMENTAL
Intervention: IV glutamine
Number of subjects: 55
Study 25800685 — intervention group
Group type: COMPARATOR
Intervention: Ca/Mg infusion
Number of subjects: 55
Study 23907080 — intervention group
Group type: EXPERIMENTAL
Intervention: Sleep group
Number of subjects: 24
Study 23907080 — intervention group
Group type: COMPARATOR
Intervention: No-sleep group
Number of subjects: 24
Study 21294018 — intervention group
Group type: EXPERIMENTAL
Intervention: Ergonomic chair and notebook riser with participatory ergonomics training
Number of subjects: 0
Study 21294018 — intervention group
Group type: EXPERIMENTAL
Intervention: PDA data adjusted for hours of computer use
Number of subjects: 0
Study 21294018 — intervention group
Group type: COMPARATOR
Intervention: Control group (no ergonomic intervention)
Number of subjects: 0
Study 19293352 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactate (Lac) solution
Number of subjects: 13
Study 19293352 — intervention group
Group type: COMPARATOR
Intervention: Lactate/bicarbonate (Lac/Bic) solution
Number of subjects: 13
Study 16400650 — intervention group
Group type: EXPERIMENTAL
Intervention: Menatetrenone (45 mg daily)
Number of subjects: 61
Study 16400650 — intervention group
Group type: COMPARATOR
Intervention: Control group (no menatetrenone)
Number of subjects: 61
Study 15523321 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent intravenous low-dose dobutamine therapy
Number of subjects: 20
Study 15523321 — intervention group
Group type: COMPARATOR
Intervention: Control subjects
Number of subjects: 20
Study 11354888 — intervention group
Group type: EXPERIMENTAL
Intervention: Diets high in oleic acid, alpha-linolenic acid, fish or fish oil, and near-vegetarian diets
Number of subjects: 0
Study 11354888 — intervention group
Group type: COMPARATOR
Intervention: Cholesterol-lowering diet
Number of subjects: 0
Study 9304358 — intervention group
Group type: EXPERIMENTAL
Intervention: Ondansetron 4 mg i.v. 10 min before induction of anaesthesia (Group A)
Number of subjects: 120
Study 9304358 — intervention group
Group type: EXPERIMENTAL
Intervention: Ondansetron 4 mg i.v. 10 min before end of surgery (Group B)
Number of subjects: 120
Study 9304358 — intervention group
Group type: COMPARATOR
Intervention: Placebo at both administration times (Group C)
Number of subjects: 120
Study 8279987 — intervention group
Group type: EXPERIMENTAL
Intervention: bezafibrate (200mg t.i.d.)
Number of subjects: 126
Study 8279987 — intervention group
Group type: EXPERIMENTAL
Intervention: simvastatin (10-40mg q.p.m.)
Number of subjects: 126
Study 8279987 — intervention group
Group type: COMPARATOR
Intervention: Control group (placebo)
Number of subjects: 126
Study 3820443 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose bismuth subsalicylate (2 tablets, 262 mg each, four times daily)
Number of subjects: 182
Study 3820443 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose bismuth subsalicylate (1 tablet, 262 mg each, four times daily)
Number of subjects: 182
Study 3820443 — intervention group
Group type: COMPARATOR
Intervention: Placebo (four times daily)
Number of subjects: 182
Study 31047791 — intervention group
Group type: EXPERIMENTAL
Intervention: Adaptive tutorials
Number of subjects: 81
Study 31047791 — intervention group
Group type: COMPARATOR
Intervention: Peer-reviewed web-based resources
Number of subjects: 81
Study 27912106 — intervention group
Group type: EXPERIMENTAL
Intervention: Bright light therapy (BLT); details on dosage and duration not available.
Number of subjects: 0